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I PI437 I Simuttaneous Detection of Mononucleosis 
Syndrome Serology Madcers Using an EIA 
Dipstick System 
B. Kiehl', E. Lennette'. 'GenBio, San Diego, C A ,  USA, 
Berkelq: C A ,  USA 
Objective and Methods: Dipsticks detecting IgG to Epstein-Barr 
virus viral capsid antigen (VCA), Epstein-Barr virus recombinant 
nuclear antigen type-1 (EBNA-l), cytomegalovirus (CMV) and tox- 
oplasma and IgM to heterophile, EBV-VCA, and CMV are evaluated 
and compared to latex (heterophile), indirect immunofluoresence 
(IFA) and enzyme immunoassay (EIA) results. 
Results: Six (1.8%) out of four hundred twenty-five samples sub- 
mitted from patients with suspect mononucleosis syndrome were 
heterophile latex positive and the dipstick product classified all as 
positives. The corresponding EBV profiles supported EBV mononu- 
cleosis for all eleven samples. One (0.3%) additional sample is identi- 
fied as a current or recent EBV infection based on VCA-IgG reactiv- 
ity and EBNA-IgG nonreamvity. An additional 25 (7.6%%) samples 
are CMV IgM reactive. Twenty samples (6.0%) that are neither EBV 
nor CMV reactive and twoplasma IgG were detected. 
Conclusions: Agreement between individual assay methods are 
all greater than 90%. Simultaneous detection of all EBV mononu- 
cleosis syndrome markers is feasible. Additionally, detection of a sig- 
nificant number of primary and/or recurrent CMV infections that 
presumably may cause the mononucleosis episode is illustrated. 
Virolab, 
1 PI438 I Comparison of lmrnunofluorescence with 
Enzyme lmmunoassay f o r  Detection of Semm 
Immunoglobulin G Response to Human 
Herpesvirus 6 
E Mesa, F! Campo, A. Guerra-Neira, R. Martinez-Zapico. Dpt. of 
Microbioloa, La Par Hospital, Madrid, Spain 
Objectives: To evaluate indirect immunofluorescence assay (IFA) 
and enzyme immunoassay (EIA) for the detection of immunoglobu- 
lin G antibodies to human herpesvirus 6 (HHV-6). 
Methods: We tested 250 serum samples by IFA (HHV-6 IgG IF1 
Kit, Bios GmbH, Miinchen, Germany) and EIA (HHV-6 IgG EIA, 
Biotrin International, Dublin, Ireland). 
Results: The fkquency of distribution of the samples according 
to IFA test titers and results obtained by EIA were: 
IFA test tircr No. of serum rvnpln No. posiovc by EIA (%) No. negative by EIA ( O h )  
N@VC 
1/20 
1/40 
1/80 
11160 
1/360 
11640 
1/1280 
I"eSpCdf,C 
65 
62 
22 
48 
14 3
9 
5 
12 
16 (24.6) 
29 (46.8) 
42 (87.5) 
13 (93) 
13 (100) 
12 (54.5) 
9 (100) 
5 (100) 
'2 (100) 
49 (75.4) 
33 (53.2) 
10 (45.5) 
6 (12.5) 
1 (7.1) 
0 
0 
0 
0 
Conclusions: We have found discrepancies in the results obtained 
by IFA and EIA, mainly when low titers resulted by IFA analysis. 
Viral hemohagic fevers 
-1 Coagulation Disorders in Children with Viral 
Hemorrhagic Fever 
E.C.M. v a ~ ~  Gorp', C. Suharti', T.E. Setiati', M.S. Trastotenojo3, 
H. ten Cate 
D.P.M. Brandjes '. 'Department ofhternal Medicine Slotemart hospital 
Amsterdam, Netherlands, ZDepartment of Internal medicine Univmity of 
Diponegoro Semarang, Indonesia, 'Pediatric department Uniwnity of 
Diponegoro Semarang, Indonesia, 4Department of Internal medicine 
Catholic University Nimegen, Netherlands, 5Centerfor hemostasis, 
thrombosis, atherosclerosis and infimmation, A M C ,  Amsterdam, 
Netherlands 
Objectives: Viral hemorrhagic fever e.g. Dengue hemorrhagic fever 
PHF) ,  is an acute febrile disease complicated by bleeding and/or 
shock. Activation of the coagulation cascade and fibrinolysis is stud- 
ied in a p u p  of children with severe hemorrhagic fever. 
Methods: During the period JulyIOctober 1996 all children (28) 
admitted to the intensive care unit with the clinical diagnosis of 
Dengue hemorrhagc fever enrolled the study. Patients were clin- 
ically classified as DHF I11 and N, according to WHO criteria. 
Markers of coagulation and fibrinolysis were sampled on three suc- 
cessive days, starting at the day of admittance and one sample on the 
day of discharge. 
Results Eight patients died. Mean age of all patients 6.5 years. 
Early in the &ease there was an evident increase in markers of 
thrombin generation. (values at day of adnuttance, SUMVOK vs. 
deaths). F1 + 2 hgments (median 2.4 vs. 5.9; p < 0.05; normal 
cl.1 nmolll), TAT complexes (median 22 vs. 81 mg/l; p < 0.05; 
normal t4 .1  mgll), fibrinogen was decreased (mean +- sd 1.6 
+- 0.8 vs. 1.4 +- 0.3 gfl; ns; normal 1.7-4.0 gll),. Fibrinolysis 
increased during hospital stay, most obvious in the non SUMVOK, 
measured as D h e r s  (third day after admittance, median 457 vs. 
649 ng/ml; p < 0.05; normal <39 ng/ml). 
Conclusions: Hemorrhagic fever in children is characterized by 
dmeminated intravascular coagulation PIC) ,  probably one of the 
contributive factors to the often dramatic outcome. 
M. Keuter ', W, Dolmans ', A. van der Ende ', 
I PI440 I Disorders of Hemostasis and Fibrinolysis in the 
Hemohagic Fever 
DZ. eengit, E. B e w t ,  S. TelalbaSit, N. Koluder. Clinic infem'ous 
diseases, Sarajevo Institute Med. University, Sarajevo, Bosnia 
In 57 patients suEering h m  hemorrhagic fever /Hantaan = Pum- 
malla virosis/hemostasis and fibrinolysis were followed. The analysis 
showed the fkquent acceleration of trombocitopania and fibrinoly- 
sis. The most frequent was trombocitopenia-at 32 patients, primary 
trombocitopenia 19, and secondary 13. Fibrinolysis was acceleration 
in 25 out of 57 observed patients, DIC was detected at two patients. 
Primary fibrinolysis is more &quently/l5/, secondary at 10 pa- 
tients. It was more kequently venfied at the onset of the disease, 
when the greatest acceleration was noticed 98/min with the ap- 
proximate one of 116. In the later course of the disease, fibrinolysis 
was present together which the developed azotemia &ve the grave 
course of disease. It was noticed that early fibrinolysis had more 
benign course. Also, trombocitopenia and fibrinolysis in this stage 
were shorter in duration and endid without the therapy, while the 
secondary with azotemia can provoke malignant bleeding, because 
of which it was necessary to apple antiplasmin in fibrinolysis, or 
heparin in DIC. 
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Viral Hemorragic Fever in Pregnancy 
S Baljogevit 
Clinical-Hospital Centre, Rijrina, Yugoslavia, 'Institute qf PathoZoa, 
Faculty of Medidne, Riftina, Yugoslavia 
Evolution of pregnancy and development of embryo during exis- 
tence of infectious &eases has been the subject of many investi- 
gations due to pathological changes in pregnancy with numerous 
complication for a mother. 
Within 1986-1995 we have treated 300 patients suffering from 
Hemorrhagic Fever, type Hantaan (with ludney syndrome) and 
Congo-Crimean Fever (CCHF). The latter had severe course with 
evident consumable coagulopathy manifested by hemorrhagic shock 
and abundant skin and mucous membrane bleeding and also bleeding 
fiom gastro-intestinal organs. 
Only four pregnant women suffering from CCHF (table 1) were 
registered. 
C. Vujitit ', N. Mitit '. 'Clinic of Infectious Diseases, 
~ 
Age O&d Gnv Dunuon of dnerr Result 
Pregnancy (months) (&PI 
29 6 VlIl 8 
30 8 VI 10 
39 7 IV 8 
24 4 111 3 
Ex Ex 
Ex Ex 
Ex Ab 
Ab 
In the eight month of pregnancy we have premature baby dies 
immediately after being born: mother dies 8 days later. In the sixth 
month a baby is born dead: mother dies 10 days later. In the fourth 
month embryo is dead mother dies 8 days later. The forth pregnant 
woman was in third month of pregnancy, had abortion at home 
followed by rich bleeding at the beginning of h e s s  and after being 
treated at our clinic she survived and has been cured without negative 
results. 
We condude that CCHF is very severe acute dectious disease 
for mother and her foetus, too. There is also danger for medical s t a E  
and family members due to high risk of transmitting virus by blood. 
I P1442 I Serological Evidence of the Presence of 
Hantaviral Serotypes in Montenegro 
N. Vu&rG, B. Andrit, A. Jusumfianit. Clinical Hospital 
Cenfre-Montenegro, Podgorica, Montenegro 
The aim of b s  study was to assess the circulation of merent Han- 
tavid serotypes in Montenegro in 1995. 
Hantavirus infection has been explored for h o s t  30 years. These 
viruses are maintained in nature as chronic infection and cause dis- 
eases in humans every five to ten yean. 
In 1995, we treated 128 patients (Clinical Hospital Centre, Ward 
of Infectuous Disease). Clinical picture varied f?om mild to severe. 
Sera b m  128 patients were examined by IFA using merent han- 
t a d  antigenes (Institute ofVirology, Belgrade, S. Tomanovit). 
The serological investigation showed the following results: diag- 
nosis was serologically confirmed in 82% cases. The seropositivity 
was found in a high percentage: both serotypes Hantan (HTN) and 
Puumala (Pvv) in 14%, HTN in 58%, and P W  in 20% cases. 
In condusion we can say that HTN serotype Section ranked 
first. The findings for both serotypes (HTN, P W )  corresponded to 
the severity of illness. PUU dection caused mild form of disease. 
I PI4431 Cellular Immune Defence in the Pathogenesis 
of Hemorrhagic Fever with Renal Syndrome 
(HFRSI 
A. Markotit I ,  A. G a p  ', S. Rabatit I ,  A. Sabioncello ', G. D a Z  
I. Kuman2, D. Dekaris '. 'Institute oflmmunofogy, Zagreb, Croatia, 
University Hospitalfor Infectious Diseases, Zugreb, Croatia 
Objectives: The a z n  of our study was to measure proinflammatory 
cytokines that may have a role in the pathogenesis of HFRS. 
Methods: We use EM-test ( Q u a n h e ,  R&D Systems Inc., UK) 
for the detection of IL-2, I L - ~ s ~ ,  IL-6 and IL-6sR in sera of 41 
HFRS patients. Samples were collected among the Croatian soldiers 
during the greatest HFRS outbreak in Croatia in 1995. During the 
outbreak, we were looking for immunophenotypic changes in the 
main lymphocyte populations and activation markers in 22 HFRS 
patients. 
Results: We found elevated levels of IL-2&, IL-6 and IL-6sR 
in patients with HFRS in comparison to healthy controls. IL-ZsRa 
and IL-6 showed negative correlation with the day after the onset 
of HFRS. In 14 patients 2 s b  positively correlated with the CD25, 
an early activation marker (detected during the study in 1995). In 
the same patients we also found positive correlation among the IL-6 
and CD2O*CD21+ double-positive B-lymphocytes, CD23, B-cell 
activation marker and CD4+ and CD8+-lymphocytes simultaneously 
expressing both CD45RA and CD45RO markers. 
Conclusions: We found an increase of tested proinflammatory 
cytokines in the early phase of HFRS. Also we could consider that 
measured cytokines acts as an autocrine and paracrine factors, driv- 
ing the expansion of antigen-specific lymphocytes and influencing 
the activity of the other cells within the immune system. Our next 
aim would be to correlate chical and biochemical data with the 
immune response, and to look for their role in the prognosls of 
HFRS. 
1 P1444 1 Evaluation of Two Commercial Dengue Fever 
Assays verses an IgM Specific Neutralization 
L. Cullman, W Hogrefe. M R L  Bagnosticc Cypress, c4, USA 
Objective: To assess the specificity and sensitivity of two commer- 
cial DFV assays in comparison to IgM specific viral neutralization. 
Method: A panel of 30 selected low IgM positive samples pm- 
vided by the CDC, San Juan, PR. and 5 normal sera from a 
non-endemic region were tested. Prior to performing the neutral- 
ization assay, IgG was removed by treating the samples with goat 
anti-human IgG. The commercial assays compared included the 
MRL Diagnostics g capture ELISA and Genelabs Diagnostics IgM 
Blot. Samples were tested per kit manufacturers' instructions. 
Results: The h r t y  IgM low positive samples all had speclfic 
IgM neutralizing antibodies. Two samples had only type 1 DFV 
neutralizing antibodies, 11 had only type 2, 1 had only type 4. 
There were no samples with type 3 DFV neutralizing antibodes. 
The remaining 16 samples had antibodies specific to more than one 
DFV All five normal samples were negative. Viral neutralization 
was detected using IFA. The MRL Diagnostics p capture ELISA 
detected IgM in 29 of the 30 samples for sensitivity of 96.7%. The 
Genelabs Diagnostics Blot detected IgM m 20 of 30 for a sensitivity 
of 66.7%; seven samples were indeterminate. Both the MRL and the 
Genelabs assays had 100% specificity 
Conclusion: The MRL I.L capture ELISA showed sigdcandy 
better correlation with IgM wal neutralization than the Genelabs 
Blot. 
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ml Dengue Shock Syndrome (DSS): Liver 
Involvement in Fatal versus Non Fatal Cases 
C. Suharti I ,  T.E. Setiati I ,  M.S. Tmtotenojo 
Djokomoeljanto ', G. Rahmanin grum', J. Setiabudi', E.C.M. van 
Gorp ', WM.V Dolmans '. 'School ofMedicine, Diponegoro University, 
Dr. Kariadi Hospital Semarang, Indonesia, *Department of Internal 
Medicine Slotemart Hospital Amsterdam, The Netherlands, 3Department 
of Internal Medicine, Katholic University of Nijmegen, The Netherlands 
Objectives: To get c h c a l  pictures and laboratory h h g s  con- 
cerning liver involvement in DSS. 
Methods: Cross sectional study. Fivety children DSS patients 
admitted to Dr. Kariadi Hospital hm.June  24, 1996 to Decem- 
ber 10, 1996, were evaluated for physical examination, laboratory 
tests: SGOT, SGPT, Total protein, Albumine, A k a h e  phosphatase, 
Gamma-GT and Prothrombin time. We also measured TNF level in 
13 out of 50 DSS cases. 
Results: Hepatomegdy was found in 88% of cases. Laboratory 
findings fatal vs non fatal cases were: the median of SGOT was 
(143 vs 76) u/l, SGPT (41.50 vs 26) u/l, Alk. Phosphatase (115 vs 
138) u/l, Gamma-GT (31 vs 17) u/l, Total protein (4.50 vs 4.65) 
g/dl, Albumine (3.30 vs 3.50) g/dl, Prothrombine time (18 vs 14.6) 
seconds. The TNF data b m  13 cases showed, that there seems to 
be very high level in fatal cases. 
Conclusions: 1. Hepatomegaly was found in 88% cases of DSS. 
2. Hlgh level of SGOT, SGPT, low level of total protein and albu- 
mine, and prolonged of prothrombin time were found in DSS, but 
more remarkable in fatal cases. 3. The level of alkaline phosphatase 
and Gamma-GT were relatively normal. 4. There seems to be very 
high level TNF in fatal cases. 5. The correlation between the pro- 
longed of prothrombine time and high level of TNF needs further 
investigation. 
H. Setiawan I ,  
I P1446 I C1Q Induces Conformational Changes into the 
A. Vladyko, T. Shkolina, V. Zaytseva. Research Instifute of 
Epidemiology and Microbidon, Minsk, Belarus 
It was shown that a guinea pig complement, being added to anti- 
gen in Lassa virus ELSA-test, intensdied sensitivity and specificity 
of the assay. The analysis of mice antibodies spectrum, involved in 
this phenomenon, demonstrated that the intensification of method's 
sensitivity as much as 8-16 times took place in polisterol plate sensi- 
bhation with antibodies of IgG2a and IgG2b subclasses and when 
the complement was added to antigen. 
On the basis of footprinting data it was proved, that after bind- 
ing to antigen-antibody immune complex, the complement induced 
conformational changes in antigen. 
Footprinting and ELISA data permitted us to assume, that the 
Clq component of the complement and MAbs of various isotypes, 
specific to NF' protein of Lassa virus, induced changes in antigen in 
different ways, affecting various antigen-active sites. 
NP of Lassa Virus Antigen 
Miscellaneous viruses 
I P1447 False Positive Results in the Serologic 
Diagnostic of the Human Parvovims B19 
Infection 
M. Rivera, A. Menasalvas, F! Gijbn, F! Catalin, 
C. Sinchez-Carrillo, E. Bouza. Hospital General Gregorio Mamtibn, 
Madrid, Spain 
Parvovirus B19 (PVB) is a DNA virus recently implicated in a wide 
spectrum of human diseases. IgM antibody detection constitutes the 
easiest and most available dngnostic procedure for recent infections. 
From January 1993 to December 1995, our laboratory received 
the request to determine IgM-PVB (Parvo-Bl9 EM IgM test, 
MarDx Diagnostics) in 584 clinical samples. Of these, 95 samples 
h m  65 patients were positive. We were able to find adequate clinical 
information in 46 cases. Twelve cases (26%) were considered "false 
positive": Ten adults with liver transplantation with acute CMV in- 
fection (positive viral culture), a child with measles mfection (clinical 
presentation and seroconversion) and one case with EBV infectious 
mononucleosis (IgM). The remaining 34 cases had c h c a l  mani- 
festations well described in relation to PVB: Seven were pediatric 
patients, the most of them with erythema infectiosum, 7 healthy 
young women presented arthralgias or erythematous-mh illness, 16 
were HN-positive patients with persistent anemia and 4 other pa- 
tients had hematological disorders. Most frequent signs were: anemia 
(58%), s h  lesions (47%), fever (38%) and arthralgias (20%). 
The high rate of "false positive" in our study warns against over- 
interpretation of the results. 
ml Persistence of Human Parvovirus B19 DNA in 
Bone Marrow of Heatthy Donors 
F? Cassinotti I ,  G. Burtonboy *, G. Siegl I .  'Instifufefor Cliniral 
Microbiology and Immunology, St. Galkn, Switzerland, Uniuenid 
Catholique de Louuain, Bnucelles, Belgium 
Objectives: To mvesngate the presence of human parvovirus B19 
(B19V) in bone marrow of healthy bone marrow donors. 
Methods: Presence of B19V DNA was tested in blood and/or 
bone marrow samples obtained h m  a total of 45 healthy bone mar- 
row donors using a nested polymerase chain reaction assay (nPCR). 
The serological status of the donors was determined by enzyme im- 
munoassay (EM). 
Results: B19V DNA was detected in the bone m m w  of 4 out 
of 45 donors (9%). Among serum samples available h m  39 donors 
none tested positive for B19V DNA, 28 (72%) contained anti-B19 
IgG antibody only as a sign of past infection, and none contained 
anti-B19 IgM antibody. Anti-B19 IgG antibody was detected in each 
serum sample available for 3 of the 4 individuals with B19-DNA in 
bone marrow. 
Conclusions: These results indicate that B19V may persist in 
the bone marrow of 11% (3/28) of donors with serologically docu- 
mented past B19V infection. 
I PI449 I The Polyomyelitis in Kosovo and Metohia in 
1996 Year 
N. Cvetkovic, S. BaljoSeviS, C. VujiZiC, R. Katanic, N. Popovic, 
S. Stojanovit. The Clinic ofI$ecriue Diseases, fiutina, Yugoslavia 
In places where antiepidemic measures were not applied properly 
and hygienic conditions of life are bad, epidemic form of disease are 
possible. The aim of this work is to point on differency of clinical 
picture and epidemiological characteristics epidemy of polyomyeli- 
